China SXT Pharmaceuticals Statistics
Total Valuation
SXTC has a market cap or net worth of $17.52 million. The enterprise value is -$2.58 million.
Important Dates
The last earnings date was Monday, August 19, 2019, before market open.
| Earnings Date | Aug 19, 2019 |
| Ex-Dividend Date | n/a |
Share Statistics
SXTC has 116.03 million shares outstanding. The number of shares has increased by 21,127.69% in one year.
| Current Share Class | 116.03M |
| Shares Outstanding | 116.03M |
| Shares Change (YoY) | +21,127.69% |
| Shares Change (QoQ) | +4,650.01% |
| Owned by Insiders (%) | 35.33% |
| Owned by Institutions (%) | 0.27% |
| Float | 75.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.82 |
| Forward PS | n/a |
| PB Ratio | 0.87 |
| P/TBV Ratio | 0.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.37, with a Debt / Equity ratio of 0.06.
| Current Ratio | 4.37 |
| Quick Ratio | 4.04 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.25 |
Financial Efficiency
Return on equity (ROE) is -50.30% and return on invested capital (ROIC) is -22.61%.
| Return on Equity (ROE) | -50.30% |
| Return on Assets (ROA) | -18.27% |
| Return on Invested Capital (ROIC) | -22.61% |
| Return on Capital Employed (ROCE) | -41.10% |
| Revenue Per Employee | $20,506 |
| Profits Per Employee | -$118,265 |
| Employee Count | 75 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 0.70 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.11% in the last 52 weeks. The beta is 1.40, so SXTC's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | -96.11% |
| 50-Day Moving Average | 1.44 |
| 200-Day Moving Average | 1.67 |
| Relative Strength Index (RSI) | 24.70 |
| Average Volume (20 Days) | 10,638,056 |
Short Selling Information
| Short Interest | 150,150 |
| Short Previous Month | 175,896 |
| Short % of Shares Out | 0.13% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.68 |
Income Statement
In the last 12 months, SXTC had revenue of $1.54 million and -$8.87 million in losses. Loss per share was -$0.15.
| Revenue | 1.54M |
| Gross Profit | 334,395 |
| Operating Income | -8.38M |
| Pretax Income | -8.87M |
| Net Income | -8.87M |
| EBITDA | -8.34M |
| EBIT | -8.38M |
| Loss Per Share | -$0.15 |
Full Income StatementBalance Sheet
The company has $21.31 million in cash and $1.20 million in debt, with a net cash position of $20.10 million or $0.17 per share.
| Cash & Cash Equivalents | 21.31M |
| Total Debt | 1.20M |
| Net Cash | 20.10M |
| Net Cash Per Share | $0.17 |
| Equity (Book Value) | 20.23M |
| Book Value Per Share | 0.17 |
| Working Capital | 20.08M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.74 million and capital expenditures -$2,023, giving a free cash flow of -$2.74 million.
| Operating Cash Flow | -2.74M |
| Capital Expenditures | -2,023 |
| Free Cash Flow | -2.74M |
| FCF Per Share | -$0.02 |
Full Cash Flow StatementMargins
| Gross Margin | 21.74% |
| Operating Margin | -544.94% |
| Pretax Margin | -576.72% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SXTC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21,127.69% |
| Shareholder Yield | -21,127.69% |
| Earnings Yield | -50.63% |
| FCF Yield | -15.65% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 25, 2025. It was a reverse split with a ratio of 1:8.
| Last Split Date | Feb 25, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
SXTC has an Altman Z-Score of 4.61 and a Piotroski F-Score of 3.
| Altman Z-Score | 4.61 |
| Piotroski F-Score | 3 |
